Hepatitis B vaccine and central nervous system demyelinating diseases

Pediatric Infectious Disease Journal

Volumn 18, Issue 1, 1999, Pages 23-24

  Halsey, N A ^a   Duclos, P ^a   Van Damme, P ^a   Margolis, H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Central nervous system demyelinating disease; Hepatitis B; Hepatitis B vaccine; Multiple sclerosis; Vaccine safety

Indexed keywords

HEPATITIS B VACCINE;

CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; DRUG SAFETY; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INFECTION PREVENTION; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK BENEFIT ANALYSIS; VIRUS REACTIVATION;

EID: 0032956631     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199901000-00007     Document Type: Review

References (0)